|

Precision Imaging to Evaluate Kaposi Sarcoma

RECRUITINGN/ASponsored by Washington University School of Medicine
Actively Recruiting
PhaseN/A
SponsorWashington University School of Medicine
Started2026-04-10
Est. completion2028-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06898203

Summary

AIMS 2 \& 3: In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria - Aim 2 (Patients):

* Adults age ≥18 years old
* Histopathology-confirmed Kaposi Sarcoma
* At least 3 skin lesions
* Capable of informed consent
* On treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 2 (Patients):

* Patients not initiating Kaposi Sarcoma treatment
* Very ill patients requiring hospitalization

Inclusion Criteria - Aim 3 (Patients):

* Adults age ≥18 years old
* Histopathology-confirmed Kaposi Sarcoma
* Capable of informed consent
* Initiating treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 3 (Patients):

* Patients with Kaposi Sarcoma that participated in Aim 1 or Aim 2
* Prior or ongoing Kaposi Sarcoma treatment

Conditions2

CancerKaposi Sarcoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.